جمعه 8 اسفند 1404
تاریخ ایجاد: یکشنبه 28 فروردین 1401   تاریخ بروزرسانی: سه شنبه 2 اردیبهشت 1404    تعداد بازدید : 481

 

 

Index

Title of Article

Row

ISI,PubMed,Scopus

Okhovat A.A, Advani S, Ziaadini B, Panahi A, Salehizadeh S, Nafissi Sh, Haghi Ashtiani B, Rajabally Y, and Fatehi F. The value of MUNIX as an objective electrophysiological biomarker of disease progression in chronic inflammatory demyelinating polyneuropathy. Muscle & nerve, 2022;65(4):433-439. IF:3.4

1
Scopus

Dehghan P, Nasab SH, Meimand HA. The effectiveness of adaptive working memory training on EEG and cognitive performance in Alzheimer disease. Cognition, Brain, Behavior, 2022 Mar 30;26(1):19-36

2
ISI,PubMed,Scopus

Sadeghi R, Masoudi MR, Patelarou A, Khanjani N. Predictive Factors for the Care and Control of Hypertension Based on the Health Belief Model Among Hypertensive Patients During the COVID-19 Epidemic in Sirjan, Iran. Current Hypertension Reviews. 2022 Apr 1;18(1):78-84. IF:2.3

3
ISI,PubMed,Scopus

Ziaadini B, Karimi N, Panahi A, Okhovat AA, Fatehi F, Nafissi S. A retrospective study of the safety and efficacy of rituximab in Iranian patients with myasthenia gravis: A singlecenter experience. Curr J Neurol 2022; 21(2): 91-97. IF:0.7

4
ISI, Scopus Khazaneha M, Tajedini O, Esmaeili O, Abdi M, Khasseh AA, Sadatmoosavi A. Thematic evolution of coronavirus disease: a longitudinal co-word analysis. Library Hi Tech. 2022 Apr 12;41(1):7-24. IF:3.4 5
ISI,PubMed,Scopus Ghadiri F, Sahraian MA, Baghbanian SM, Ashtari F, Razazian N, Majdinasab N, Poursadeghfard M, Hatamian H, Harirchian MH, Beladimoghadam N, Azimi A. Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years. Multiple sclerosis and related disorders. 2022 May 1;61:103777. IF:4 6
Scopus

Heydari F, Shahesmaeili A, Eslami Shahrbabaki M. Comparison of Personality Types and Alexithymia between Opiates Dependents, Concurrent Opiates and Methamphetamine Users and Control Group Referred to Drug Abuse Treatment Centers in Kerman City in 2020. Iranian Journal of Epidemiology. 2022 May 10;18(1):69-78.

7
ISI,PubMed,Scopus

Kamali H, Hosseini S, Aliabadi HR, Poursadeghfard M, Sahraian MA, Eskandarieh S. Increasing Incidence and Male to Female Sex Ratio of Multiple Sclerosis in Tehran, Iran: A Population-Based Study. Iranian Journal of Public Health. 2022 May 8;51(5):1193-4. IF:1.4

8
ISI,PubMed,Scopus

Torkaman M, Momennasab M, Yektatalab S, Shahrbabaki ME. Psychometric analysis of Persian version of patient safety competency self-evaluation in psychiatric wards. Journal of Education and Health Promotion. 2022 Jun 1;11(1):154. IF:1.4

9
Google Scholar

Sepehri far S, Sahebozamani M, Ebrahimi HA. Effects of 8 Weeks Antigravity Swing Exercise on Functional Ability of Walking and Upper Body in Multiple Sclerosis Women with Moderate Disability. Journal of Paramedical Sciences & Rehabilitation. 2022;11(1):28-36.

10
 

Sepehri far S, Amiri B, Sahebozamani M, Ebrahimi H.A. Multi-function Swing Suspension Training in Multiple Sclerosis: Assessing the Influence on Upper and Lower Extremities Function and Quality of Life with Respect to Expanded Disability Status Scale. Sport Sciences & Therapy. Preprints 2022, 2022070006 (doi: 10.20944/preprints202207.0006.v1).

11
ISI,Scopus Davarani ER, Takaloo FM, Daneshi S, Sanjari P, Khanjani N, Hushmandi K, Raei M. Assessing the phenylketonuria (PKU) neonatal screening program and the incidence rates of PKU in Kerman County, Iran: a health system research. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM). 2022 Jul 29;11(2):e110217. IF:0.4 12
ISI,Scopus

Azin H, Vakilian A, Najafi MR, Seifaddini R, Azin M. Progressive fulminant necrotizing myelitis in COVID-19 infection; case report of a rare complication. Annals of Indian Academy of Neurology. 2022 Jul 1;25(4):781-785. IF:1.7

13
DOAJ

Torkian S, Khosravi V, Etesami R, Jaafari Z, Morowatisharifabad M, Ahmadi A, Khanjani N. Knowledge, Attitudes, and Practices Towards COVID-19 in Iran: A Population-Based Study. International Journal of Epidemiologic Research, 2022; 9(2): 61-68. doi: 10.34172/ijer.2022.11

14
ISI,PubMed,Scopus

Khanjani N, Farahmandfard MA, Eslahi M. A Review of studies using Air Q software for prediction of Air Pollution Health effects in Iran. Current Environmental Health Reports. 2022 Sep;9(3):386-405. https://doi.org/10.1007/s40572-022-00362-8. IF:7.9

15
ISI,PubMed,Scopus

Farzinmehr S, Hosseini S, Kamali H, Moghadasi AN, Poursadeghfard M, Sharifi MH. Association of self-reported adherence to the Mediterranean diet with anthropometric indices, comorbidities, and degree of disability in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 2022 Oct 1;66:104060. IF:4

16
Scopus

Rezapour M, Nezam Tabar A, Khanjani N. Fear of Bullying Victimization in Middle School: Types of Victimization and Advocacy Considerations. Int Journal of Bullying Prevention, 2022 Jan;4(2):89–98. https://doi.org/10.1007/s42380-021-00089-4

17
ISI,PubMed,Scopus Ebrahimi H A, Jafari M, Khanjani N, Moradi N. Evaluation of date extract on nerve conduction velocity in male ratBasic and Clinical Neuroscience, 2022; 13 (3):385-392. IF:1.7 18
ISI,PubMed,Scopus Borhani‐Haghighi A, Hooshmandi E, Zahediasl F, Molavi Vardanjani H, Rezaei M, Rahimi‐Jaberi A, Ashjazadeh N, Petramfar P, Ostovan VR, Fadakar N, Poursadeghfard M. Early and mid‐term outcomes of carotid angioplasty and stent placement in 579 patients. Journal of Neuroimaging. 2022 Aug 15. https://doi.org/10.1111/jon.13036 IF:2.4 19
ESCI(ISI) Farahmandfard MA, Ebrahimi HA, Khanjani N, Mirzaee M. Air Pollution and Hospital Admission for Epilepsy in Kerman, Iran. Health Scope. 2022 Aug 31;11(3):e124245. IF:0.6 20
ISI,PubMed,Scopus

Motaghi N, Tajadini H, Shafiei K, Sharififar F, Ansari M, Sharifi H, Sarhadynejad Z, Tavakoli-Far F, Kamali H, Amiri-Ardekani E. Lavender improves fatigue symptoms in multiple sclerosis patients: A double-blind, randomized controlled trial. Multiple Sclerosis and Related Disorders. 2022 Sep 1;65:104000. IF:4

21
ISI,PubMed,Scopus

Yousefi F, Asadikaram G, Karamouzian S, Abolhassani M, Pourghadamyari H, Moazed V, Khanjani N, Paydar P. Organochlorine and organophosphorus pesticides may induce brain cancer through oxidative stress. Toxicology and Industrial Health. 2022 Sep 30. https://doi.org/10.1177/07482337221125954. IF:1.9

22
ISI,PubMed,Scopus

Najmadini A, Mohammadi MM, Langroudi L, Meimand HE, Mahmoodi M, Mirzaei M. Increased expression of PD-1 in CD8+ CD3+ T cells correlates with EBV viral load in MS patients. Journal of NeuroVirology. 2022 Oct 15:1-8. IF: 3.2

23
PubMed,Scopus

Torkaman M, Momennasab M, Yektatalab S, Eslami shahrbabaki M. Nurses' patient safety competency, a predictor for safe care in psychiatric wards?. Perspectives in Psychiatric Care. 2022 Oct;58(4):2854-61.

24
PubMed

Eslami Shahrbabaki M, Barfehie D, Mazhari S, Ahmadi A, Shafiee  S. Comparing Cognitive Functions in Patients with Schizophrenia and Methamphetamine-Induced Psychosis with Healthy Controls. Addiction and Health, 2022; 14(4): 239-43. doi: 10.34172/ahj.2022.1143

25
ISI,PubMed,Scopus

Sepehri Far S, Amiri B, Sahebozamani M, Ebrahimi HA. Improvement in the multiple sclerosis functional composite score by multi-function swing suspension training program. Multiple Sclerosis and Related Disorders. 2022 Nov 1;67:104174. IF:4

26
ISI,PubMed,Scopus

Kiani Z, Asadikaram G, Faramarz S, Salimi F, Ebrahimi H. Pesticide Exposure and Alzheimer’s Disease: A Case-control Study. Current Alzheimer Research. 2022 Nov 1;19(13):892-903. IF:2.1

27
ISI,PubMed,Scopus

Nasiri N, Ilaghi Nezhad M, Sharififar F, Khazaneha M, Najafzadeh MJ, Mohamadi N. The Therapeutic Effects of Nigella sativa on Skin Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine. 2022 Dec 5;2022. IF:2.65

28
Scopus

Shahrbabaki ME, Ahmadipour H, Yousefi N, Divsalar P. Tit Treatment Satisfaction Questionnaire for Medication (TSQM Version II): A Psychometric Properties Analysis. International Journal of High Risk Behaviors and Addiction. 2022 Dec 31;11(4).

29
ISI,PubMed,Scopus

Najmadini A, Mohammadi MM, Langroudi L, Meimand HE, Mahmoodi M, Mirzaei M. Increased expression of PD-1 in CD8+ CD3+ T cells correlates with EBV viral load in MS patients. Journal of NeuroVirology. 2022 Dec;28(4-6):497-504. IF:3.2

30
ISI,PubMed,Scopus

Afshar PJ, Afsharmanesh J, Eslahi M, Sheikhbardsiri H, Moghadam MN. Determination risk factors for severe and profound hearing loss in child candidates for cochlear implantation in southeast of Iran during 2014-2020. BMC pediatrics. 2022 Dec;22(1):1-6. IF:2.4

31
Scopus Iranmanesh F, Arvan H, Ahmadipour H, Gadari F, Barzegar H, et al. Tramadol Abuse-associated Seizure: An Epidemiological and Electroencephalographic Study. Int J High Risk Behav Addict. 2022;11(4):e127462. https://doi.org/10.5812/ijhrba-127462 32
Scopus Daneshi S, Mohseni Takaloo F, Rezabeigi Davarani E, Pourabazari GH. Incidence rate and causes of new cases of major β-thalassemia after implementation of national prevention program in Kerman University of Medical Sciences, 2011 to 2019. The Iranian Journal of Obstetrics, Gynecology and Infertility.2023 Jan;25 (11):34-46. 33
ISI,Scopus

Sadeghi R, Khanjani N, Hashemi M. Explaining the reasons for the tendency of youth to hookah smoking: a qualitative study. Journal of Substance Use. 2023 Jan 2;28(1):74-8. IF:0.8

34
ISI,PubMed,Scopus

Ghadiri F, Asadollahzadeh E, Ebadi Z, Sahraian MA, Azimi A, Navardi S, Heidari H, Abna Z, Aboutorabi M, Adibi I, Baghbanian SM, Paybast S, Poursadeghfard M, Hosseini S, Shahmohammadi S, Ghaffari M, Ghalyanchi-Langroodi H, Ghiasian M, Kamali H, Kouchaki E, Mahrabi F, Mohammadianinejad E, Nahayati MA, Moghadasi AN. Iranian specialists' approach to treatment escalation in multiple sclerosis patients with cognitive impairment. Curr J Neurol. 2023 Jan 5;22(1):1-7. doi: 10.18502/cjn.v22i1.12610. IF:0.7

35
ISI,PubMed,Scopus

Ghadiri F, Sahraian MA, Razazian N, Ashtari F, Poursadeghfard M, Nabavi SM, Navardi S, Baghbanian SM, Shaygannejad V, Harirchian MH, Beladimoghadam N. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics. Multiple sclerosis and related disorders. 2023 Feb 1;70:104493. IF:4

36
ISI

Sadeghi R, Khanjani N. COVID-19 and health culture. Environmental Health Engineering And Management Journal. Winter 2023;10(1):121-122. IF:1.6

37